Cargando…
Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status
PURPOSE: Ultrafine particles (UFP) are toxic due to their small size and penetration into deeper lung compartments. We aimed to evaluate the exhaled breath condensate (EBC)-UFP content as a reflection of inflammation and oxidative stress status in COPD patients and as an exacerbation risk marker. ME...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402613/ https://www.ncbi.nlm.nih.gov/pubmed/30880945 http://dx.doi.org/10.2147/COPD.S187560 |
_version_ | 1783400425898115072 |
---|---|
author | Fireman Klein, Einat Adir, Yochai Krencel, Amir Peri, Regina Vasserman, Bella Fireman, Elizabeth Kessel, Aharon |
author_facet | Fireman Klein, Einat Adir, Yochai Krencel, Amir Peri, Regina Vasserman, Bella Fireman, Elizabeth Kessel, Aharon |
author_sort | Fireman Klein, Einat |
collection | PubMed |
description | PURPOSE: Ultrafine particles (UFP) are toxic due to their small size and penetration into deeper lung compartments. We aimed to evaluate the exhaled breath condensate (EBC)-UFP content as a reflection of inflammation and oxidative stress status in COPD patients and as an exacerbation risk marker. METHODS: EBC was collected by conventional methods. Particles were analyzed with NanoSight LM20. EBC carbonyl and 8-hydroxydeoxyguanosine (8-OHdG) levels were measured using ELISA kits. Study population (58 COPD patients and 40 healthy smoker and non-smoker controls) underwent spirometry, diffusion capacity, EBC testing, and blood sampling. RESULTS: Absolute eosinophil count, C-reactive protein (CRP), and lactate dehydrogenase in serum were elevated in the COPD group compared with the controls (224 U/L, 5 mg/L, and 391 U/L vs 154 U/L, 3 mg/L, and 330 U/L, P=0.009, P=0.05, and P=0.004, respectively). COPD patients had lower UFP concentrations in EBC compared with controls (0.24 E8/mL vs 0.51 E8/mL, P≤0.001). A mirror image was detected in serum: COPD patients had higher UFP concentrations compared with controls (9.8 E8/mL vs 6.7 E8/mL, respectively, P=0.03). EBC carbonyl and 8-OHdG levels were higher among COPD patients compared with controls (5.1 per 1 µg/mL protein and 0.036 ng/mL vs 0.41 per 1 µg/mL protein and 0.003 ng/mL, P=0.001 and P≤0.001, respectively). EBC UFP concentrations were negatively correlated with pack years (R=−0.44, P ≤0.001) and positively correlated with FEV(1) and diffusing lung capacity for carbon monoxide (R=0.46, 0.23, P ≤0.001 and P=0.04, respectively). Low EBC UFP concentrations (≤0.18 E8/mL) and CRP levels ≥5 mg/L were independent predictors of the frequent exacerbator phenotype (OR 3.6; 95% CI: 1.06–7.97; P=0.04 and OR 4.4; 95% CI: 1.24–10.2; P=0.02, respectively). CONCLUSION: UFP content in EBC reflects the inflammatory state of airways. Low UFP concentrations in EBC and high in serum of COPD patients support our hypothesis that increased epithelial permeability could be the mechanism behind those findings. |
format | Online Article Text |
id | pubmed-6402613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-64026132019-03-16 Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status Fireman Klein, Einat Adir, Yochai Krencel, Amir Peri, Regina Vasserman, Bella Fireman, Elizabeth Kessel, Aharon Int J Chron Obstruct Pulmon Dis Original Research PURPOSE: Ultrafine particles (UFP) are toxic due to their small size and penetration into deeper lung compartments. We aimed to evaluate the exhaled breath condensate (EBC)-UFP content as a reflection of inflammation and oxidative stress status in COPD patients and as an exacerbation risk marker. METHODS: EBC was collected by conventional methods. Particles were analyzed with NanoSight LM20. EBC carbonyl and 8-hydroxydeoxyguanosine (8-OHdG) levels were measured using ELISA kits. Study population (58 COPD patients and 40 healthy smoker and non-smoker controls) underwent spirometry, diffusion capacity, EBC testing, and blood sampling. RESULTS: Absolute eosinophil count, C-reactive protein (CRP), and lactate dehydrogenase in serum were elevated in the COPD group compared with the controls (224 U/L, 5 mg/L, and 391 U/L vs 154 U/L, 3 mg/L, and 330 U/L, P=0.009, P=0.05, and P=0.004, respectively). COPD patients had lower UFP concentrations in EBC compared with controls (0.24 E8/mL vs 0.51 E8/mL, P≤0.001). A mirror image was detected in serum: COPD patients had higher UFP concentrations compared with controls (9.8 E8/mL vs 6.7 E8/mL, respectively, P=0.03). EBC carbonyl and 8-OHdG levels were higher among COPD patients compared with controls (5.1 per 1 µg/mL protein and 0.036 ng/mL vs 0.41 per 1 µg/mL protein and 0.003 ng/mL, P=0.001 and P≤0.001, respectively). EBC UFP concentrations were negatively correlated with pack years (R=−0.44, P ≤0.001) and positively correlated with FEV(1) and diffusing lung capacity for carbon monoxide (R=0.46, 0.23, P ≤0.001 and P=0.04, respectively). Low EBC UFP concentrations (≤0.18 E8/mL) and CRP levels ≥5 mg/L were independent predictors of the frequent exacerbator phenotype (OR 3.6; 95% CI: 1.06–7.97; P=0.04 and OR 4.4; 95% CI: 1.24–10.2; P=0.02, respectively). CONCLUSION: UFP content in EBC reflects the inflammatory state of airways. Low UFP concentrations in EBC and high in serum of COPD patients support our hypothesis that increased epithelial permeability could be the mechanism behind those findings. Dove Medical Press 2019-03-01 /pmc/articles/PMC6402613/ /pubmed/30880945 http://dx.doi.org/10.2147/COPD.S187560 Text en © 2019 Fireman Klein et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Fireman Klein, Einat Adir, Yochai Krencel, Amir Peri, Regina Vasserman, Bella Fireman, Elizabeth Kessel, Aharon Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status |
title | Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status |
title_full | Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status |
title_fullStr | Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status |
title_full_unstemmed | Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status |
title_short | Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status |
title_sort | ultrafine particles in airways: a novel marker of copd exacerbation risk and inflammatory status |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402613/ https://www.ncbi.nlm.nih.gov/pubmed/30880945 http://dx.doi.org/10.2147/COPD.S187560 |
work_keys_str_mv | AT firemankleineinat ultrafineparticlesinairwaysanovelmarkerofcopdexacerbationriskandinflammatorystatus AT adiryochai ultrafineparticlesinairwaysanovelmarkerofcopdexacerbationriskandinflammatorystatus AT krencelamir ultrafineparticlesinairwaysanovelmarkerofcopdexacerbationriskandinflammatorystatus AT periregina ultrafineparticlesinairwaysanovelmarkerofcopdexacerbationriskandinflammatorystatus AT vassermanbella ultrafineparticlesinairwaysanovelmarkerofcopdexacerbationriskandinflammatorystatus AT firemanelizabeth ultrafineparticlesinairwaysanovelmarkerofcopdexacerbationriskandinflammatorystatus AT kesselaharon ultrafineparticlesinairwaysanovelmarkerofcopdexacerbationriskandinflammatorystatus |